GSK3B and breast carcinoma: Moreover, elimination of natural killer cell cytotoxicity via promoted expression of natural killer (NK) cell ligands is done by pSer535-eIF2B following the expression of pSer9-GSK-3β (inactive GSK3β) and generation of ROS, which promotes breast cancer growth and metastasis (105).